VS | ||||
---|---|---|---|---|
Variables | All individuals (n = 1,356) | Individuals without DESH (n = 1,331) | ||
βSTD | P-value | βSTD | P-value | |
Age | 0.3199 | < 0.0001* | 0.3082 | < 0.0001* |
Female sex | −0.2343 | < 0.0001* | −0.2423 | < 0.0001* |
Education (≤ 9 years) | −0.0243 | 0.3478 | −0.0126 | 0.6329 |
Hypertension | −0.0080 | 0.7602 | −0.0085 | 0.7486 |
Diabetes mellitus | 0.0447 | 0.0772 | 0.0391 | 0.1279 |
Dyslipidemia | −0.0428 | 0.0913 | −0.0429 | 0.0953 |
Atrial fibrillation | 0.0146 | 0.5592 | 0.0186 | 0.4644 |
Coronary artery disease | 0.0225 | 0.3718 | 0.0072 | 0.7777 |
Heart failure | 0.0094 | 0.7067 | 0.0160 | 0.5306 |
BMI | −0.0151 | 0.5538 | −0.0126 | 0.6282 |
History of smoking | −0.0129 | 0.6835 | −0.0134 | 0.6785 |
Fazekas score | 0.1473 | < 0.0001* | 0.1504 | < 0.0001* |
Lacunar infarction | −0.0571 | 0.0692 | −0.0803 | 0.0117* |
Microbleeds | 0.0112 | 0.6673 | 0.0078 | 0.7668 |
Perivascular space | 0.0425 | 0.0888 | 0.0411 | 0.1047 |
SF | ||||
---|---|---|---|---|
Variables | All individuals (n = 1,356) | Individuals without DESH (n = 1,331) | ||
βSTD | P-value | βSTD | P-value | |
Age | 0.3280 | < 0.0001* | 0.3152 | < 0.0001* |
Female sex | −0.0704 | 0.0310* | −0.0588 | 0.0756 |
Education (≤ 9 years) | 0.0104 | 0.6955 | 0.0225 | 0.4029 |
Hypertension | 0.0206 | 0.4416 | 0.0123 | 0.6488 |
Diabetes mellitus | 0.0228 | 0.3766 | 0.0231 | 0.3771 |
Dyslipidemia | −0.0299 | 0.2468 | -0.0213 | 0.4157 |
Atrial fibrillation | 0.0539 | 0.0355* | 0.0767 | 0.0031* |
Coronary artery disease | 0.0189 | 0.4622 | 0.0041 | 0.8737 |
Heart failure | 0.0166 | 0.5166 | 0.0212 | 0.4129 |
BMI | −0.0036 | 0.8888 | 0.0046 | 0.8623 |
History of smoking | 0.0446 | 0.1677 | 0.0490 | 0.1361 |
Fazekas score | 0.0707 | 0.0259* | 0.0629 | 0.0503 |
Lacunar infarction | 0.0046 | 0.8849 | 0.0072 | 0.8251 |
Microbleeds | 0.0093 | 0.7268 | 0.0169 | 0.5295 |
Perivascular space | 0.0456 | 0.0733 | 0.0538 | 0.0372* |
SHM | ||||
---|---|---|---|---|
Variables | All individuals (n = 1,356) | Individuals without DESH (n = 1,331) | ||
βSTD | P-value | βSTD | P-value | |
Age | −0.1104 | 0.0002* | −0.0833 | 0.0063* |
Female sex | 0.0717 | 0.0363* | 0.0650 | 0.0619 |
Education (≤ 9 years) | 0.0015 | 0.9563 | −0.0158 | 0.5765 |
Hypertension | −0.0632 | 0.0246* | −0.0624 | 0.0288* |
Diabetes mellitus | −0.0006 | 0.9809 | 0.0061 | 0.8234 |
Dyslipidemia | −0.0052 | 0.8469 | −0.0159 | 0.5635 |
Atrial fibrillation | 0.0064 | 0.8105 | −0.0078 | 0.7741 |
Coronary artery disease | −0.0124 | 0.6459 | 0.0041 | 0.8808 |
Heart failure | −0.0120 | 0.6538 | −0.0187 | 0.4930 |
BMI | −0.0311 | 0.2559 | −0.0360 | 0.1963 |
History of smoking | −0.0306 | 0.3680 | −0.0355 | 0.3045 |
Fazekas score | −0.1601 | < 0.0001* | −0.1525 | < 0.0001* |
Lacunar infarction | 0.0242 | 0.4735 | 0.0352 | 0.3024 |
Microbleeds | 0.0074 | 0.7920 | 0.0063 | 0.8242 |
Perivascular space | −0.0822 | 0.0022* | −0.0888 | 0.0011* |